Study guide

15.1 Behavioral Change: Motivational Interviewing, Models & Theories

ANCC Adult-Gerontology Primary Care Nurse Practitioner AGPCNP-BC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The AGPCNP-BC Examination: Blueprint, Format & Scoring

1.1 The AGPCNP-BC Blueprint, Exam Format, Scoring, Eligibility & Renewal

2 Chapter 2: Assessment Foundations & Lifespan Considerations

2.1 Comprehensive Health History, Symptom Analysis & Lifespan Variations 2.2 Physical Examination Techniques & Age-Related Physiological Changes 2.3 Functional Assessment (Katz ADL / Lawton IADL) & Frailty Syndromes 2.4 Psychosocial, Nutritional, Cognitive & Mental Health Screening Instruments 2.5 Health Screening Guidelines (USPSTF) & Adult Immunization Schedules (CDC/ACIP)

3 Chapter 3: Diagnostic Reasoning & Clinical Interpretation

3.1 Diagnostic Reasoning, Clinical Decision-Making & Differential Diagnosis Formulation 3.2 Routine & Specialized Laboratory Interpretation 3.3 Diagnostic Imaging, ECG Interpretation & Pulmonary Function Testing 3.4 Evidence-Based Testing, Pre-Test Probability & Choosing Wisely Principles

4 Chapter 4: Cardiovascular Disorders

4.1 Hypertension: 2025 AHA/ACC Guideline, Resistant HTN & Secondary HTN 4.2 Dyslipidemia & ASCVD Risk Calculation, Statin Therapy & Non-Statin Agents 4.3 Coronary Artery Disease, Stable Angina & Post-ACS Outpatient Management 4.4 Heart Failure (HFrEF/HFpEF), Atrial Fibrillation & Peripheral Vascular Disease

5 Chapter 5: Respiratory Disorders

5.1 Asthma: GINA 2026 Guidelines, Phenotypes, Stepwise Pharmacotherapy & Action Plans 5.2 COPD: GOLD 2026 Report, ABE Staging, Triple Inhalers & Exacerbations 5.3 Lower Respiratory Infections (CAP, Bronchitis), Pleural Disease & Solitary Pulmonary Nodules

6 Chapter 6: HEENT & Allergic/Immunologic Disorders

6.1 Eye & Vision Disorders in Adult-Gerontology Primary Care 6.2 Ear, Hearing & Vestibular Disorders 6.3 Nose, Sinus, Oropharyngeal & Oral Cavity Disorders 6.4 Allergic & Immunologic Disorders: Anaphylaxis, Urticaria, Angioedema & Immunodeficiency

7 Chapter 7: Endocrine & Metabolic Disorders

7.1 Type 2 Diabetes Mellitus: ADA Standards of Care, Pharmacotherapy & Microvascular Complications 7.2 Thyroid Disorders: Hypothyroidism, Hyperthyroidism, Thyroiditis & Nodules 7.3 Adrenal & Pituitary Disorders: Adrenal Insufficiency, Cushing's, Hyperaldosteronism & Hypopituitarism 7.4 Metabolic Bone Disease: Osteopenia, Osteoporosis (FRAX, DEXA) & Hyperparathyroidism

8 Chapter 8: Gastrointestinal & Hepatic Disorders

8.1 Upper GI Disorders: GERD, Barrett's Esophagus, PUD, H. pylori & Gastritis 8.2 Lower GI Disorders: Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD) & Diverticular Disease 8.3 Hepatobiliary Disorders: MASLD/MASH, Viral & Alcoholic Hepatitis, Cirrhosis & Cholelithiasis 8.4 Acute & Chronic Abdominal Pain Syndromes, GI Bleeding & Colorectal Cancer Screening

9 Chapter 9: Renal, Urological & Men's Health

9.1 Chronic Kidney Disease: KDIGO Staging, Albuminuria Management & Renoprotective Strategies 9.2 Urinary Tract Infections (Uncomplicated, Complicated, Recurrent), Pyelonephritis & Microscopic Hematuria 9.3 Men's Health: Benign Prostatic Hyperplasia, Prostatitis, Epididymitis & Erectile Dysfunction

10 Chapter 10: Musculoskeletal & Rheumatologic Disorders

10.1 Degenerative & Overuse Musculoskeletal Disorders: Osteoarthritis, Tendinopathies & Spine Disorders 10.2 Autoimmune Rheumatologic Disorders: Rheumatoid Arthritis, SLE, Polymyalgia Rheumatica & Giant Cell Arteritis 10.3 Crystal Arthropathies & Fibromyalgia: Gout, Pseudogout & Centralized Pain Syndromes

11 Chapter 11: Neurological & Psychiatric Disorders

11.1 Headaches (Migraine, Tension, Cluster) & Cranial Neuralgias 11.2 Cerebrovascular Disease, TIA, Peripheral Neuropathies & Movement Disorders (Parkinson's) 11.3 Mood & Anxiety Disorders: Major Depressive Disorder, Generalized Anxiety Disorder & PTSD 11.4 Substance Use Disorders: Alcohol, Tobacco, Opioids & Cannabis in Primary Care

12 Chapter 12: Dermatologic, Hematologic & Infectious Disease

12.1 Primary Dermatologic Lesions, Inflammatory Dermatoses & Cutaneous Malignancies 12.2 Common Infectious Diseases: Skin/Soft Tissue Infections, Tick-Borne Illnesses & Viral Syndromes 12.3 Sexually Transmitted Infections (STIs): CDC Guidelines, Screening & Partner Management 12.4 Hematologic Disorders: Anemias (Microcytic, Normocytic, Macrocytic), Leukopenia & Coagulopathies

13 Chapter 13: Geriatric Syndromes, Pharmacology & Palliative Care

13.1 The Geriatric 5Ms Framework, Multimorbidity & Polypharmacy Deprescribing 13.2 Beers Criteria 2023 Update & STOPP/START Prescribing Rules 13.3 Pharmacokinetics, Pharmacodynamics & Pharmacogenomics Across the Adult Lifespan 13.4 Dementia vs. Delirium vs. Depression: Differential Diagnostics & Management 13.5 Falls, Mobility Impairment, Pressure Injury Prevention & Palliative Care Transitions

14 Chapter 14: Gynecologic & Women's Health

14.1 Contraceptive Management, Emergency Contraception & Preconception Counseling 14.2 Perimenopause, Menopause & Hormone Replacement Therapy (HRT) 14.3 Gynecologic Infections (Vaginitis, PID), Abnormal Uterine Bleeding & Cervical Cancer Screening (USPSTF/ASCCP)

15 Chapter 15: Plan-of-Care Process: Behavior Change, Education & Care Coordination

15.1 Behavioral Change: Motivational Interviewing, Models & Theories 15.2 Patient Education, Shared Decision-Making, Referrals, Care Coordination & Plan Reassessment

16 Chapter 16: APRN Professional Practice, Ethics, Policy & Quality Improvement

16.1 APRN Scope of Practice, Consensus Model, Collaborative Practice & Credentialing 16.2 Bioethics, Informed Consent, Advance Directives & Surrogate Decision-Making 16.3 Environmental & Social Determinants of Health, Health Equity & Culturally Responsive Care 16.4 Evidence-Based Practice (EBP), Quality Improvement (QI) Methodologies & Healthcare Economics

15.1 Behavioral Change: Motivational Interviewing, Models & Theories

Key Takeaways Explain This Topic AI

The Transtheoretical Model stages are precontemplation, contemplation, preparation, action and maintenance, and the intervention must be matched to the stage rather than defaulting to advice-giving.

The four core motivational interviewing skills are captured by OARS: open-ended questions, affirmations, reflective listening and summarizing.

The righting reflex, the clinician's urge to argue for change, reliably produces sustain talk and is the single most common motivational interviewing error.

The 5 A's framework for tobacco cessation is Ask, Advise, Assess, Assist and Arrange, and the 5 R's (relevance, risks, rewards, roadblocks, repetition) is used for patients not yet willing to quit.

Readiness rulers ask the patient to rate importance and confidence from 0 to 10, and the productive follow-up question is why the number is not lower, which elicits change talk.

Last updated: August 2026

Behavioral Change: Motivational Interviewing, Models & Theories

Most of what determines a patient's health happens outside your examination room. Tobacco use, physical inactivity, diet, alcohol, medication adherence and self-monitoring drive outcomes in every chronic disease this guide covers. The ANCC blueprint names behavioral change (motivational interviewing, models, theories) as a knowledge statement under Implementation and Evaluation, and these items are answered by identifying the patient's readiness and choosing the matching communication response - not by choosing the most forceful piece of advice.

1. The Transtheoretical (Stages of Change) Model

Prochaska and DiClemente's model describes change as a cyclical process , not a single decision. The exam tests whether you can name the stage from a quotation and select the stage-matched intervention. +---------------------------------------------------------------------------------------------------+

  • | TRANSTHEORETICAL MODEL: STAGE, CUE AND MATCHED RESPONSE |
  • | |
  • | 1. PRECONTEMPLATION (no intention within 6 months) |
  • | Patient says: "I don't have a drinking problem. My wife is the one who is upset." |
  • | DO: Raise awareness without arguing. Ask permission to share information. Explore the |
  • | patient's own concerns. Leave the door open. DON'T: set a quit date, hand a pamphlet |
  • | and lecture, or warn about consequences they did not ask about. |
  • | |
  • | 2. CONTEMPLATION (intends to change within 6 months; AMBIVALENT) |
  • | Patient says: "I know I should quit, but smoking is the only thing that calms me down." |
  • | DO: Explore ambivalence. Decisional balance - pros and cons of changing AND of not changing. |
  • | Elicit and reinforce change talk. Develop discrepancy between values and behavior. |
  • | |
  • | 3. PREPARATION (intends to act within 30 days; has taken a small step) |
  • | Patient says: "I bought the patches. I'm going to quit after my daughter's wedding." |
  • | DO: Collaborative planning. Set a quit date, arrange pharmacotherapy, anticipate triggers, |
  • | build a support plan, write a SMART goal. |
  • | |
  • | 4. ACTION (has changed the behavior for < 6 months) |
  • | Patient says: "I haven't had a cigarette in three weeks." |
  • | DO: Affirm effort, problem-solve barriers, reinforce self-efficacy, schedule close follow-up. |
  • | |
  • | 5. MAINTENANCE (sustained > 6 months) |
  • | DO: Relapse prevention. Identify high-risk situations, rehearse coping plans. |
  • | |
  • | RELAPSE is expected and is a normal part of the cycle, not a failure. Reframe it as a learning |
  • | event, avoid shaming, and re-enter the cycle at the patient's current stage. |
  • +---------------------------------------------------------------------------------------------------+

The most commonly tested error is applying an action-stage intervention - setting a quit date, prescribing varenicline, writing an exercise prescription - to a precontemplative patient. Doing so produces defensiveness and damages the relationship without changing behavior.

2. Two Other Models Worth Knowing

Health Belief Model. A person acts when they believe they are susceptible to a condition that is severe , that the benefits of action outweigh the barriers , when a cue to action prompts them, and when they have self-efficacy . It is a useful diagnostic lens: a patient who declines colonoscopy because "nobody in my family ever had cancer" has low perceived susceptibility, while one who says "I can't take a day off and I have no one to drive me" has a barrier. Those two patients need entirely different responses, and offering statistics to the second one accomplishes nothing.

Social Cognitive Theory (Bandura). Behavior is shaped by reciprocal determinism among the person, the behavior and the environment. Its most actionable construct is self-efficacy , the belief that one can perform the behavior, which is built by mastery experiences (start with an achievable goal), vicarious experience (peer models), verbal persuasion and attention to physiological states.

3. Motivational Interviewing

Motivational interviewing (Miller and Rollnick) is a collaborative, goal-oriented style of communication that strengthens a person's own motivation and commitment to change by attending to the language of change in an atmosphere of acceptance and compassion.

The spirit (PACE): P artnership, A cceptance, C ompassion, E vocation. The clinician is a partner rather than an expert dispensing corrections, and motivation is evoked from the patient rather than installed into them.

The four processes, in sequence:

Engaging - establish a working relationship.

Focusing - agree on the target behavior together.

Evoking - elicit the patient's own arguments for change. This is the heart of the method.

Planning - build a concrete change plan once the patient is ready.

OARS - the four core skills:

Skill What it is Example

O pen-ended questions Cannot be answered yes or no "What would need to be different for you to consider cutting back?"

A ffirmations Recognize genuine strengths and effort, not flattery "You came back after a hard month. That takes persistence."

R eflective listening Statements, not questions, that mirror or deepen meaning "Drinking is how you unwind, and you're worried about what it's doing to your liver."

S ummarizing Collects and links what the patient said, especially change talk "So you're proud of the walking, frustrated by the numbers, and thinking about the medication again."

Change talk versus sustain talk. Change talk is any patient speech favoring change, remembered as DARN-CAT : D esire, A bility, R easons, N eed, then the mobilizing forms C ommitment, A ctivation and T aking steps. Sustain talk favors the status quo. Your job is to selectively elicit, reflect and reinforce change talk and to avoid arguing against sustain talk.

  • Warning
  • The righting reflex. The clinician's instinct to fix, warn and correct is the single most common
  • motivational interviewing error. When you argue for change, the ambivalent patient reliably takes
  • the other side and argues against it - and people are persuaded by what they hear themselves
  • say. Discord ("you don't understand my situation") and sustain talk are signals to change your

approach, not evidence that the patient is non-compliant. Respond by rolling with resistance :

reflect, emphasize personal choice and autonomy, reframe, or shift focus.

Four practical techniques:

Ask-Tell-Ask. Ask what the patient already knows and whether they want information; tell it briefly and neutrally; ask what they make of it.

Elicit-Provide-Elicit. The same structure applied to advice, which preserves autonomy.

The readiness ruler. "On a scale of 0 to 10, how important is it to you to lose weight? How confident are you that you could?" Then ask the productive question: "Why a 5 and not a 2?" - which forces the patient to articulate their own reasons for change. Asking "why not an 8?" elicits sustain talk and is the wrong direction.

Developing discrepancy. Gently juxtapose the behavior with a value the patient has already stated: "You've told me being at your grandson's graduation matters more than anything. Where does the smoking fit with that?"

4. Structured Frameworks for Specific Behaviors

The 5 A's (the USPSTF-endorsed framework for tobacco cessation, adaptable to any behavior):

  • Step Action
  • Ask Screen for the behavior at every visit and document it

Advise Give clear, strong, personalized advice ("Quitting smoking is the most important thing you can do for your COPD")

  • Assess Determine willingness to make an attempt now
  • Assist Provide counseling, pharmacotherapy, quitline referral and a written plan
  • Arrange Schedule follow-up, ideally within the first week after a quit date

The 5 R's , for a patient not yet willing to attempt change: R elevance (why change matters to this patient), R isks (their personal risks), R ewards (their personal benefits), R oadblocks (barriers and how to address them), and R epetition (revisit at every visit without nagging).

SBIRT - S creening, B rief I ntervention, R eferral to T reatment - is the structure for alcohol and drug use: screen with AUDIT-C or a single-item screener, deliver a brief 5 to 15 minute motivational conversation for risky use, and refer for a probable use disorder.

Writing the goal. Collaborative goals should be SMART : specific, measurable, achievable, relevant and time-bound. "Exercise more" is not a plan; "walk 15 minutes after dinner on Monday, Wednesday and Friday, starting this week, and bring the log to our visit in 4 weeks" is. Then close the loop with teach-back and document the goal so the next visit can begin with reassessment rather than starting over.